AVROBIO, Inc. (AVRO) stock rallied over 1.98% intraday to trade at $0.94 a share on NASDAQ. The stock opened with a gain of 2.17% at $0.928 and touched an intraday high of $0.97, rising 2.17% against the last close of $0.92. The stock went to a low of $0.92 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends2021-12-30
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, for the treatment of Pompe disease; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-06 that is in preclinical stage for the treatment of Gaucher disease type 3. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
AVROBIO, Inc. (NASDAQ: AVRO) stock price is $0.94 as of the last check on Tuesday, July 5. During the trading session, AVRO stock reached the peak price of $0.97 while $0.92 was the lowest point it dropped to.
The NASDAQ listed AVRO is part of Biotechnology industry that operates in the broader Health Care sector. AVROBIO, Inc. , a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide.
Mr. Kim Raineri M.B.A.
Chief Manufacturing & Technology Officer
Ms. Georgette Verdin
Chief HR Officer
Mr. Geoff MacKay BSc
Co- Founder, Pres, CEO & Director
Mr. Erik John Ostrowski M.B.A.
CFO & Treasurer
AVRO stock traded closed the last session at $0.938, which is $0.02 or 1.98% lower than its previous close of $0.92. AVRO's current trading price is 26.80% lower than its 52-week high of $9.37 where as its distance from 52-week low of 0.74% is -89.99%.
Number of AVRO employees currently stands at -. AVRO operates from Building 300, Suite 201 One Kendall Square, Cambridge, MA 02139, United States.
Official Webiste of $AVRO is: https://www.avrobio.com
AVRO stock volume for the day was 201,584 shares while in the previous session number of AVRO shares traded was 176,593 . The average number of AVRO shares traded daily for last 3 months was 506.41 Thousands.
The percentage change in AVRO stock occurred in the recent session was 1.98% while the dollar amount for the price change in AVRO stock was $0.02.
In the recent session, the day high for AVRO stock was $0.97 while the low for AVRO stock touched on the day was $0.92.
The market value of AVRO currently stands at 41 Million with its latest stock price at $0.94 and 43.7 Million of its shares outstanding.